Literature DB >> 18790993

Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension.

Kathryn N Farrow1, Satyan Lakshminrusimha, William J Reda, Stephen Wedgwood, Lyubov Czech, Sylvia F Gugino, Jonathan M Davis, James A Russell, Robin H Steinhorn.   

Abstract

Endothelial nitric oxide (NO) synthase (eNOS) expression and activity are decreased in fetal lambs with persistent pulmonary hypertension (PPHN). We sought to determine the impact of mechanical ventilation with O(2) with or without inhaled NO (iNO) or recombinant human SOD (rhSOD) on eNOS in the ductal ligation model of PPHN. PPHN lambs and age-matched controls were ventilated with 100% O(2) for 24 h alone or combined with 20 ppm iNO continuously or a single dose of rhSOD (5 mg/kg) given intratracheally at delivery. In 1-day spontaneously breathing lambs, eNOS expression in resistance pulmonary arteries increased relative to fetal levels. eNOS expression increased in control lambs ventilated with 100% O(2), but not in PPHN lambs. Addition of iNO or rhSOD increased eNOS expression and decreased generation of reactive oxygen species (ROS) in PPHN lambs relative to those ventilated with 100% O(2) alone. However, only rhSOD restored eNOS function, increased tetrahydrobiopterin (BH(4)), a critical cofactor for eNOS function, and restored GTP cyclohydrolase I expression in isolated vessels and lungs from PPHN lambs. These data suggest that ventilation of PPHN lambs with 100% O(2) increases ROS production, blunts postnatal increases in eNOS expression, and decreases available BH(4) in PPHN lambs. Although the addition of iNO or rhSOD diminished ROS production and increased eNOS expression, only rhSOD improved eNOS function and levels of available BH(4). Thus therapies designed to decrease oxidative stress and restore eNOS coupling, such as rhSOD, may prove useful in the treatment of PPHN in newborn infants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790993      PMCID: PMC2604791          DOI: 10.1152/ajplung.90238.2008

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  47 in total

1.  Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes.

Authors:  M C Walsh-Sukys; J E Tyson; L L Wright; C R Bauer; S B Korones; D K Stevenson; J Verter; B J Stoll; J A Lemons; L A Papile; S Shankaran; E F Donovan; W Oh; R A Ehrenkranz; A A Fanaroff
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates.

Authors:  M Vento; M Asensi; J Sastre; F García-Sala; F V Pallardó; J Viña
Journal:  Pediatrics       Date:  2001-04       Impact factor: 7.124

Review 4.  Regulation of endothelial nitric oxide synthase: location, location, location.

Authors:  Philip W Shaul
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

Review 5.  Nitric oxide synthases: structure, function and inhibition.

Authors:  W K Alderton; C E Cooper; R G Knowles
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

6.  Nitric oxide (NO) upregulates NO synthase expression in fetal intrapulmonary artery endothelial cells.

Authors:  I S Yuhanna; A N MacRitchie; R L Lantin-Hermoso; L B Wells; P W Shaul
Journal:  Am J Respir Cell Mol Biol       Date:  1999-11       Impact factor: 6.914

7.  Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group.

Authors:  R H Clark; T J Kueser; M W Walker; W M Southgate; J L Huckaby; J A Perez; B J Roy; M Keszler; J P Kinsella
Journal:  N Engl J Med       Date:  2000-02-17       Impact factor: 91.245

8.  Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs.

Authors:  C Tzao; P A Nickerson; J A Russell; S F Gugino; R H Steinhorn
Journal:  Pediatr Pulmonol       Date:  2001-02

9.  Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase.

Authors:  Lisa A Brennan; Robin H Steinhorn; Stephen Wedgwood; Eugenia Mata-Greenwood; Everett A Roark; James A Russell; Stephen M Black
Journal:  Circ Res       Date:  2003-02-27       Impact factor: 17.367

10.  Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.

Authors:  Ulf Landmesser; Sergey Dikalov; S Russ Price; Louise McCann; Tohru Fukai; Steven M Holland; William E Mitch; David G Harrison
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

View more
  63 in total

Review 1.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

2.  Mechanisms underlying increased reactivity of pulmonary arteries contralateral to a localized high-flow anastomosis.

Authors:  Sandra Pfister; Lewis Somberg; Timothy Lowry; Ying Gao; Meetha Medhora; Elizabeth R Jacobs
Journal:  J Thorac Cardiovasc Surg       Date:  2010-11-13       Impact factor: 5.209

3.  Mitochondrial monoamine oxidase-A-mediated hydrogen peroxide generation enhances 5-hydroxytryptamine-induced contraction of rat basilar artery.

Authors:  Christina Chui Wa Poon; Sai Wang Seto; Alice Lai Shan Au; Qian Zhang; Rachel Wai Sum Li; Wayne Yuk Wai Lee; George Pak Heng Leung; Siu Kai Kong; John Hok Keung Yeung; Sai Ming Ngai; Ho Pui Ho; Simon Ming Yuen Lee; Shun Wan Chan; Yiu Wa Kwan
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 4.  Bringing down the ROS: a new therapeutic approach for PPHN.

Authors:  Amy L Firth; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-17       Impact factor: 5.464

Review 5.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

6.  Reactive Oxygen Species, Biomarkers of Microvascular Maturation and Alveolarization, and Antioxidants in Oxidative Lung Injury.

Authors:  Arwin M Valencia; Maria A Abrantes; Jamal Hasan; Jacob V Aranda; Kay D Beharry
Journal:  React Oxyg Species (Apex)       Date:  2018-11

Review 7.  Pharmacotherapy for pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

8.  Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach?

Authors:  Praveen Chandrasekharan; Rafal Kozielski; Vasantha H S Kumar; Munmun Rawat; Veena Manja; Changxing Ma; Satyan Lakshminrusimha
Journal:  Am J Perinatol       Date:  2016-09-14       Impact factor: 1.862

Review 9.  Persistent pulmonary hypertension of the newborn.

Authors:  Ru-Jeng Teng; Tzong-Jin Wu
Journal:  J Formos Med Assoc       Date:  2013-01-03       Impact factor: 3.282

10.  Increased p22(phox)/Nox4 expression is involved in remodeling through hydrogen peroxide signaling in experimental persistent pulmonary hypertension of the newborn.

Authors:  Stephen Wedgwood; Satyan Lakshminrusimha; Lyubov Czech; Paul T Schumacker; Robin H Steinhorn
Journal:  Antioxid Redox Signal       Date:  2013-02-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.